Discovery Labs files $200 million shelf for preferreds, debt, stock

By Devika Patel

Knoxville, Tenn., June 8 - Discovery Laboratories Inc. filed a $200 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers debt securities, preferred stock, common stock, debt warrants and equity warrants.

The securities may be structured as convertibles.

Proceeds will be used to meet working capital requirements.

Based in Warrington, Pa., Discovery develops treatments for respiratory diseases in children, adults and premature infants.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.